Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Abelein

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|May 8, 2026
Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domainLaurène Adam, Willem Hendrik Molenkamp, Jan Stanislaw Nowak, et al.
Communications Biology|May 8, 2023
Short hydrophobic loop motifs in BRICHOS domains determine chaperone activity against amorphous protein aggregation but not against amyloid formationGefei Chen, Axel Leppert, Helen Poska, et al.
The Biochemical Journal|August 13, 2016
Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in DrosophilaHelen Poska, Martin Haslbeck, Firoz Roshan Kurudenkandy, et al.
Nature Communications|February 1, 2024
Identification of potential aggregation hotspots on Aβ42 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domainRakesh Kumar, Tanguy Le Marchand, Laurène Adam, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 10, 2021
The synthesis and characterization of Bri2 BRICHOS coated magnetic particles and their application to protein fishing: Identification of novel binding proteinsHelene Tigro, Nina Kronqvist, Axel Abelein, et al.
Communications Biology|January 22, 2020
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitroGefei Chen, Yuniesky Andrade-Talavera, Simone Tambaro, et al.
Journal of the American Chemical Society|June 30, 2025
Chaperone-Mediated Regulation of Tau Phase Separation, Fibrillation, and ToxicityCecilia Mörman, Axel Leppert, Giusy Pizzirusso, et al.
Scientific Reports|January 16, 2020
High-yield Production of Amyloid-β Peptide Enabled by a Customized Spider Silk DomainAxel Abelein, Gefei Chen, Kristīne Kitoka, et al.
RSC Chemical Biology|November 9, 2022
Abilities of the BRICHOS domain to prevent neurotoxicity and fibril formation are dependent on a highly conserved Asp residueGefei Chen, Yuniesky Andrade-Talavera, Xueying Zhong, et al.
Protein Science : a Publication of the Protein Society|July 9, 2024
Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOSLaurène Adam, Rakesh Kumar, Luis Enrique Arroyo-Garcia, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|May 8, 2026
Mechanism-selective inhibition of α-synuclein aggregation by the chaperone-like BRICHOS domainLaurène Adam, Willem Hendrik Molenkamp, Jan Stanislaw Nowak, et al.
Communications Biology|May 8, 2023
Short hydrophobic loop motifs in BRICHOS domains determine chaperone activity against amorphous protein aggregation but not against amyloid formationGefei Chen, Axel Leppert, Helen Poska, et al.
The Biochemical Journal|August 13, 2016
Dementia-related Bri2 BRICHOS is a versatile molecular chaperone that efficiently inhibits Aβ42 toxicity in DrosophilaHelen Poska, Martin Haslbeck, Firoz Roshan Kurudenkandy, et al.
Nature Communications|February 1, 2024
Identification of potential aggregation hotspots on Aβ42 fibrils blocked by the anti-amyloid chaperone-like BRICHOS domainRakesh Kumar, Tanguy Le Marchand, Laurène Adam, et al.
Journal of Pharmaceutical and Biomedical Analysis|March 10, 2021
The synthesis and characterization of Bri2 BRICHOS coated magnetic particles and their application to protein fishing: Identification of novel binding proteinsHelene Tigro, Nina Kronqvist, Axel Abelein, et al.
Communications Biology|January 22, 2020
Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitroGefei Chen, Yuniesky Andrade-Talavera, Simone Tambaro, et al.
Journal of the American Chemical Society|June 30, 2025
Chaperone-Mediated Regulation of Tau Phase Separation, Fibrillation, and ToxicityCecilia Mörman, Axel Leppert, Giusy Pizzirusso, et al.
Scientific Reports|January 16, 2020
High-yield Production of Amyloid-β Peptide Enabled by a Customized Spider Silk DomainAxel Abelein, Gefei Chen, Kristīne Kitoka, et al.
RSC Chemical Biology|November 9, 2022
Abilities of the BRICHOS domain to prevent neurotoxicity and fibril formation are dependent on a highly conserved Asp residueGefei Chen, Yuniesky Andrade-Talavera, Xueying Zhong, et al.
Protein Science : a Publication of the Protein Society|July 9, 2024
Specific inhibition of α-synuclein oligomer generation and toxicity by the chaperone domain Bri2 BRICHOSLaurène Adam, Rakesh Kumar, Luis Enrique Arroyo-Garcia, et al.
Pageof 4